PubRank

Edward T H Yeh

Author PubWeight™ 79.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007 4.46
2 Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 2012 3.20
3 SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol Cell 2010 2.52
4 Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003 2.28
5 Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem 2006 2.15
6 Role of desumoylation in the development of prostate cancer. Neoplasia 2006 1.90
7 SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 2004 1.89
8 Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010 1.72
9 A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem Biophys Res Commun 2005 1.68
10 Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 2005 1.67
11 Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NFkappaB-dependent transcription. Nat Cell Biol 2006 1.62
12 Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 2004 1.55
13 Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. Mol Cell 2010 1.50
14 Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004 1.46
15 SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. Genes Cancer 2010 1.42
16 SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J 2009 1.41
17 Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem 2007 1.41
18 Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol Cell Biol 2006 1.29
19 SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem 2010 1.29
20 Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J Biol Chem 2005 1.28
21 Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. Curr Hypertens Rep 2008 1.27
22 Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res 2013 1.27
23 Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J Virol 2005 1.26
24 Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 2010 1.26
25 Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med 2008 1.24
26 Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J Cell Sci 2003 1.20
27 SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem 2010 1.16
28 Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J Biol Chem 2003 1.15
29 Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. J Clin Invest 2015 1.12
30 SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. Mol Cell 2012 1.11
31 Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J 2010 1.11
32 NF-κB induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress. Mol Cell 2011 1.09
33 Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res 2007 1.09
34 Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol 2008 1.08
35 Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. J Biol Chem 2010 1.06
36 CRP and the risk of atherosclerotic events. Semin Immunopathol 2009 1.06
37 Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 2012 1.05
38 SUMOylation and de-SUMOylation in response to DNA damage. FEBS Lett 2011 1.03
39 C-reactive protein: structure affects function. Circulation 2004 1.00
40 The pleiotropic effects of statins. Curr Opin Cardiol 2005 0.99
41 De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Circ Res 2013 0.99
42 C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 2003 0.95
43 The diagnosis and management of cardiovascular disease in cancer patients. Curr Probl Cardiol 2008 0.89
44 A new perspective on the biology of C-reactive protein. Circ Res 2005 0.87
45 Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction. Circ Cardiovasc Imaging 2011 0.86
46 Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. J Vasc Res 2005 0.84
47 PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. Tex Heart Inst J 2009 0.84
48 Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase. Mol Cancer Ther 2011 0.84
49 Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. J Clin Invest 2015 0.83
50 SUMO-specific protease 1 regulates mitochondrial biogenesis through PGC-1α. J Biol Chem 2012 0.83
51 Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches. Curr Pharm Biotechnol 2012 0.82
52 Weighing in on heart failure: the role of SERCA2a SUMOylation. Circ Res 2012 0.81
53 NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. Eur J Biochem 2004 0.81
54 The in vivo functions of desumoylating enzymes. Subcell Biochem 2010 0.81
55 An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in myostatin expression and myogenesis. J Biol Chem 2013 0.80
56 Ubiquitin, proteasome, and restenosis: a brave new world for cardiovascular research. Circulation 2002 0.79
57 Wrestling with heart failure: SUMO-1 to the rescue. Circ Res 2014 0.79
58 Fusion of the SUMO/Sentrin-specific protease 1 gene SENP1 and the embryonic polarity-related mesoderm development gene MESDC2 in a patient with an infantile teratoma and a constitutional t(12;15)(q13;q25). Hum Mol Genet 2005 0.78
59 A proatherogenic role for C-reactive protein in vivo. Curr Opin Lipidol 2005 0.76
60 Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases. Curr Atheroscler Rep 2004 0.76
61 Cardiovascular risk associated with androgen deprivation therapy. Oncology (Williston Park) 2010 0.75
62 Heparin and bone marrow-derived cell therapy: friend or foe? Circ Res 2012 0.75
63 Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans. Circ Res 2005 0.75
64 Cytokine profile and ST-elevation myocardial infarction. Circ Res 2012 0.75
65 Balancing act during development: lessons from a SUMO-less SF-1. Dev Cell 2011 0.75
66 Microphthalmia-associated transcription factor, melanoma, and renal carcinoma: the small ubiquitin-like modifier connection. Pigment Cell Melanoma Res 2011 0.75